cysteine has been researched along with cytidine diphosphate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bollinger, JM; Johnston, MI; Mao, SS; Stubbe, J | 1 |
Persson, AL; Sahlin, M; Sjöberg, BM | 1 |
Lohman, GJ; Stubbe, J; Wang, J | 1 |
Hansen, R; Li, LS; Lito, P; Rosen, N; Solomon, M | 1 |
4 other study(ies) available for cysteine and cytidine diphosphate
Article | Year |
---|---|
Mechanism-based inhibition of a mutant Escherichia coli ribonucleotide reductase (cysteine-225----serine) by its substrate CDP.
Topics: Cloning, Molecular; Cysteine; Cytidine Diphosphate; Cytosine Nucleotides; Escherichia coli; Kinetics; Mutation; Ribonucleotide Reductases; Serine | 1989 |
Cysteinyl and substrate radical formation in active site mutant E441Q of Escherichia coli class I ribonucleotide reductase.
Topics: Catalytic Domain; Cysteine; Cytidine Diphosphate; Electron Spin Resonance Spectroscopy; Escherichia coli; Free Radicals; Models, Chemical; Mutation; Ribonucleotide Reductases; Spin Trapping | 1998 |
Enhanced subunit interactions with gemcitabine-5'-diphosphate inhibit ribonucleotide reductases.
Topics: Cysteine; Cytidine Diphosphate; Deoxycytidine; Enzyme Activation; Escherichia coli; Gemcitabine; Humans; Molecular Structure; Molecular Weight; Protein Binding; Protein Subunits; Ribonucleotide Reductases; Time Factors | 2007 |
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Alleles; Antineoplastic Agents; Azetidines; Cell Line, Tumor; Cysteine; Cytidine Diphosphate; Enzyme Inhibitors; Glycine; Guanosine Triphosphate; HEK293 Cells; Humans; Lung Neoplasms; Molecular Targeted Therapy; Mutation; Piperazines; Protein Conformation; Proto-Oncogene Proteins p21(ras); Time Factors | 2016 |